The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.
Log in
-
Latest: Understanding the incretin effect and GLP1 receptor agonist therapy
Read more...
The first of 3 interactive programmes providing practical answers about GLP-1 receptor agonist therapy.
Jane Diggle and Mike Cummings discuss the practicalities of effectively initiating GLP-1 receptor agonists in daily practice.
-
Read more...
Protecting NVAF patients from stroke: appropriate dosing of DOACs
This article highlights the latest guidance on appropriate dosing of direct-acting oral anticoagulants (DOACs) in people with non-valvular atrial fibrillation (NVAF). Key considerations include specific dose adjustment requirements for each DOAC and the importance of improving patient adherence with DOAC therapy.
-
Read more...
Modern medicines series SGLT2 Inhibitors: Webinar 3 - SGLT2 inhibitors and the kidney
Professor Cliff Bailey and Dr Pam Brown discuss the reno-protective effects of SGLT2 inhibitors and their role in the management diabetic kidney disease.
-
Read more...
New resource to support high-quality anticoagulation services during and beyond the pandemic
This article describes a new best practice framework service specification which is available to download free from Anticoagulation UK. The specification has been designed to support services to deliver best practice in anticoagulation diagnosis and management during and beyond the current pandemic.
